ArticleInternational health2022
Prevalence and predictors of long-acting reversible contraceptive use among sexually active women in 26 sub-Saharan African countries.
Article in International health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 30 citations in OpenAlex.
- Free but declining: the paradox of contraceptive uptake in Burkina Faso.Frontiers in reproductive health · 2026Article
- Acceptability and Uptake of Long-Acting Reversible Contraceptives in Ethiopia: A Systematic Review and Meta-Analysis.Health science reports · 2025Review
- Correlates of long-acting reversible contraceptive (LARC) use among young women in Southern Africa: a secondary analysis from HPTN 082.medRxiv : the preprint server for health sciences · 2025Article
- Long-acting reversible methods of contraception: trends, levels, and predictors among married women of reproductive age in Nigeria.Contraception and reproductive medicine · 2025Article
- Trends and pattern of contraceptive use among women attending a family planning clinic at a tertiary health facility in Ibadan, Nigeria.BMC public health · 2025Article
- Prevalence and factors associated with the use of long-acting reversible and permanent contraceptive methods among women who desire no more children in Bangladesh.Contraception and reproductive medicine · 2025Article
- Article
- Article
- Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysis.Reproductive health · 2024Article
- Early sexual debut and pregnancy termination: uncovering the link among sexually active young women in 23 sub-Saharan African countries.Contraception and reproductive medicine · 2024Article
- Inequality gaps in modern contraceptive use and associated factors among women of reproductive age in Nigeria between 2003 and 2018.BMC women's health · 2024Article
- Determinants of postpartum long-acting reversible contraceptives in the extended postpartum period in Shashago district, Central Ethiopia: a cross-sectional study conducted in the community.Contraception and reproductive medicine · 2024Article
- Factors associated with long-acting reversible contraceptives usage among sexually active adolescent girls and young women in Zimbabwe.PLOS global public health · 2024Article
- Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.Contraception · 2024Article
- Article
- Spatial distribution and multilevel analysis of factors associated with long-acting reversible contraceptive use among sexually active women of reproductive age in Nigeria.Archives of public health = Archives belges de sante publique · 2023Article
- Expanding contraceptive choice among first-time mothers age 15-24 in Kinshasa: The Momentum pilot project.Frontiers in global women's health · 2023Article
- Postpartum long-acting reversible contraceptives use in sub-Saharan Africa. Evidence from recent demographic and health surveys data.PloS one · 2023Article
- Prevalence and determinants of intention to use modern contraceptives among grand-multiparous women in sub-Saharan Africa.Archives of public health = Archives belges de sante publique · 2022Article
- Prevalence and factors associated with the use of long-acting reversible and permanent contraceptive methods among women who desire no more children in high fertility countries in sub-saharan Africa.BMC public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-acting reversible contraceptives (LARCs) are associated with high efficacy rates and continuity of use. Based on the foregoing, we sought to examine the prevalence and factors associated with LARC use among sexually active women in 26 countries in sub-Saharan Africa(SSA).
methodsSecondary data from Demographic and Health Surveys conducted in 26 countries in SSA between January 2010 and December 2019 were pooled and analysed. A total of 56 067 sexually active women 15-49 y of age met the inclusion criteria. Bivariate and multivariate regression analyses were performed to examine the association between selected factors and the use of LARCs in SSA. Results were presented as crude odds ratios and adjusted odds ratios (aORs) with statistical precision at <0.05.
resultsThe prevalence of LARC use was 21.73%, ranging from 1.94% in Namibia to 54.96% in Benin. Sexually active women with secondary or higher education (aOR 1.19 [95% confidence interval {CI} 1.08 to 1.32]), those cohabiting (aOR 1.25 [95% CI 1.06 to 1.47]) and those with four or more children (aOR 2.22 [95% CI 1.78 to 2.78]) were more likely to use LARCs compared with those without education, never married and with no biological child.
conclusionsThe use of LARCs in the 26 countries in SSA was relatively low. Hence, the identified contributory factors of LARC use should be tackled with appropriate interventions. These include continuous campaigns on the efficacy of LARCs in reducing unintended pregnancy, maternal mortality and morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.